PMID: 8583595Mar 1, 1996Paper

Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis

The Journal of Urology
A PatelC R Woodhouse

Abstract

The application of conservative surgery has been established in the treatment of transitional cell tumors of the renal pelvis. We reviewed retrospectively the long-term outcome after percutaneous treatment of select patients referred to a tertiary center with transitional cell tumors of the renal pelvis. We studied 28 patients referred with a presumptive diagnosis of transitional cell carcinoma of the renal pelvis based on filling defects noted on excretory urograms. At percutaneous endoscopy tumor was resected in 26 patients, while no tumor was found in 2. All 19 men and 7 women smoked, and mean age at presentation was 65 years. Of the patients 18 presented with hematuria and 6 had bilateral upper tract tumors. After percutaneous resection, the access tract was irradiated either with iridium wire in 12 patients or a commercial high dose rate radiation delivery system in 12. Thiotepa was instilled into the nephrostomy tube without brachytherapy in 1 patient and 1 received no adjuvant treatment in all. All patients were followed by excretory urography and urine cytology. Cystoscopy and retrograde pyelography were performed when technically possible. After percutaneous tumor resection 6 patients (23%) had local recurrence in the ...Continue Reading

References

May 1, 1978·International Journal of Radiation Oncology, Biology, Physics·B H van der Werf-Messing
Feb 1, 1989·British Journal of Urology·G R MuftiJ P Blandy
Dec 1, 1981·British Journal of Urology·D M WallaceJ E Wickham

❮ Previous
Next ❯

Citations

May 5, 2005·Urologic Oncology·Douglas W SoderdahlDemetrius H Bagley
Dec 1, 2000·The Urologic Clinics of North America·M E Jabbour, A D Smith
Nov 7, 2003·The Journal of Urology·Ralph V Clayman
Aug 6, 2003·Critical Reviews in Oncology/hematology·Ziya Kirkali, Emre Tuzel
Feb 14, 2006·Nature Clinical Practice. Urology·Michael C OstArthur D Smith
Aug 4, 2007·Nature Clinical Practice. Urology·Jay D Raman, Douglas S Scherr
Dec 20, 2008·Advances in Urology·Georgios KoukourakisVassilios Kouloulias
Jan 7, 2009·Advances in Urology·Jeffrey John TomaszewskiMichael Cecil Ost
May 27, 2009·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Markian R Iwaszko, Amy E Krambeck
Jan 22, 2008·European Urology·Richard Zigeuner, Karl Pummer
Nov 11, 2011·Scandinavian Journal of Urology and Nephrology·Stefanos Adamis, John Varkarakis
Feb 25, 2015·Nature Reviews. Urology·Thomas SeisenMorgan Rouprêt
Sep 12, 2014·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·F AudenetP Colin
Feb 11, 2003·The Journal of Urology·Mahesh C GoelJ G Roberts
Dec 19, 2003·The Urologic Clinics of North America·Steven E CanfieldMichael J Droller
Mar 17, 2016·World Journal of Nephrology·Julia V Fiuk, Brad F Schwartz
Jul 24, 2013·Korean journal of urology·Bong Hee Park, Seong Soo Jeon
Feb 18, 1999·The Journal of Urology·P E ClarkM A Geisinger
Feb 24, 2005·Current Opinion in Urology·G Blake Johnson, Michael Grasso
Feb 17, 2006·Current Urology Reports·Fadi N JoudiMichael A O'Donnell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.